BU-NOT-SET

CONTACT US
Optimising formulation to improve solubility ready for Phase III
  • Drug product
Optimising formulation
Case study
Trends emerging in capsule dosage form development
  • Drug product
  • Industry trends
Capsules
Insight
Licensing portfolio
  • Corporate
containers
Fact sheet
Key trends in pharmaceutical outsourcing
  • Industry trends
Hands
Insight
The latest trends and innovations in oral drug delivery
  • Drug product
  • Industry trends
Pharma Roundtable
Insight
Recipharm invests in African vaccine production
  • Corporate
Building
Insight
The future of oral solid dose development and manufacturing
  • Drug product
  • Industry trends
Products
Insight
Sustainability Report 2021
  • Sustainability
Sustainability report
Report
Treating long-COVID with Erdosteine
  • Corporate
Treating long-COVID with Erdosteine
Insight
Insight
How CDMO partnerships can accelerate vaccine development
Insight
  • Analytical chemistry
  • Drug product
Optimising extractables and leachables testing
Fact sheet
  • Drug product
  • Manufacturing
Ready-to-use (RTU) pre-filled syringes and cartridges system
Insight
  • Drug product
  • Manufacturing
Recipharm’s latest investment will help meet blow-fill-seal (BFS) demand
Insight
  • Drug product
  • Industry trends
Which biologics trends in the OSD space are set to impact drug development in 2023?
Insight
  • Drug product
  • Industry trends
What are the key learnings from 2022 in pharma?
Insight
  • Drug product
  • Manufacturing
Overcoming the pitfalls of pre-filled syringe filling
Insight
  • Drug product
  • Industry trends
2023: fill and finish demand expected to continue as the industry faces new challenges
Insight
  • Drug product
  • Industry trends
What does 2023 hold for oral solid dosage forms?